Rajkumar Kannan
Chief Executive Officer at I-MAB
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jingwu Zhang Zang | M | 68 |
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | 8 years |
| Roni Mamluk | M | 57 | 18 years | |
| Richard Yeh | M | 56 |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | 2 years |
| Shuai Chen | M | 50 |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | 1 years |
| Michael Megna | M | 53 | 6 years | |
| Pamela Klein | M | 63 | 4 years | |
| Wei Fu | M | 42 | 6 years | |
| Leon Sergio Duplan Fraustro | M | 57 | 2 years | |
| Rong Shao | M | 62 | 3 years | |
| Ray Stafford | M | 77 | 8 years | |
| Timothy Stonesifer | M | 56 | 2 years | |
| Chun Kwok Au | M | 51 | 4 years | |
| David Endicott | M | 58 | 2 years | |
| Chia Hung Yang | M | 61 | 4 years | |
| Richard Levy | M | 66 | 5 years | |
| Ruyi He | M | 63 | 3 years | |
| Julie Eastwood | F | - | 5 years | |
| Jerry Wang | M | - | - | |
| Tracy Cunningham | M | - | 4 years | |
| Jonathan Balch | M | - | 2 years | |
| Helen Phillips | M | - | - | |
| Ross Moat | M | 43 | 5 years | |
| Min Yin | F | - |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | - |
| Yi Fei Zhu | M | 55 | 4 years | |
| Stephen Wills | M | 67 | 5 years | |
| Yun Han Lin | M | 46 | 7 years | |
| John McEvoy | M | 37 | 7 years | |
| Ian Bell | M | 54 | 2 years | |
| Donald Stern | M | 78 | 5 years | |
| Royce Bedward | M | 58 | 2 years | |
| Elizabeth Jobes | F | 57 | 4 years | |
| Patrick Volkert Vink | M | 60 | 5 years | |
| Alain Munoz | M | 75 | 5 years | |
| Gary Jay Sternberg | M | - | 2 years | |
| Andrew Zhu | M | - |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Benjamin McGraw | M | 75 | 8 years | |
| Paul R. Fonteyne | M | 62 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 9 years |
| Mark J. Fitzpatrick | M | 61 | 6 years | |
| Marla Persky | F | 68 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 8 years |
| Olaf Klinger | M | 59 | 4 years | |
| Casey C. Kopczynski | M | 62 | 17 years | |
| Rainer Lichtenberger | M | 65 | 14 years | |
| Joe Wiley | M | 53 | 4 years | |
| Rory Nealon | M | 56 | 4 years | |
| J. Carroll | M | 74 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 9 years |
| Xiu Xuan Zhu | M | 64 | 3 years | |
| John Scarlett | M | 73 | 6 years | |
| Michael McCleerey | M | - | 8 years | |
| Dawn Schottlandt | F | - | 1 years | |
| Veit Ulshöfer | M | 61 | 23 years | |
| Peter John McDonnell | M | 66 | 2 years | |
| Desiree Ralls-Morrison | F | 57 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 4 years |
| Drew Enamait | M | 50 | 6 years | |
| Julie McHugh | F | 59 | 7 years | |
| Matthew Emmens | M | 72 | 4 years | |
| Wolfram Carius | M | 63 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | - |
| John Doyle | M | 46 | - | |
| Rick Ryan | M | - | 11 years | |
| Ursula B. Bartels | F | 66 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 5 years |
| Brendan Classon | M | - | - | |
| Richard Croarkin | M | 69 | 7 years | |
| lee Giguere | M | 43 | 2 years | |
| Scott Minick | M | 72 | 14 years | |
| Stephen Joyce | M | - | - | |
| Thomas A. Mitro | M | 66 | 9 years | |
| David Stack | M | 72 | 7 years | |
| John W. LaRocca | M | 59 | 4 years | |
| David Gryska | M | 68 | 4 years | |
| John Thero | M | 63 | 6 years | |
| Gerald D. Cagle | M | 79 | 9 years | |
| Michael du Toit | M | 71 | 7 years | |
| Malte Peters | M | 61 | 1 years | |
| Joseph Lyons | M | - | 1 years | |
| Christophe Couturier | M | 58 | 12 years | |
| Lynne Sullivan | F | 58 | 8 years | |
| Giuseppe Ciaramella | M | 55 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 1 years |
| Lan Kang | F | 55 | 3 years | |
| Jörg Hornstein | M | 47 | 11 years | |
| Anand Varadan | M | 57 | 1 years | |
| Michael Becker | M | 76 | 13 years | |
| Jennifer Laux | F | - |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 1 years |
| Vincent R. Anicetti | M | 69 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 1 years |
| David Smoller | M | 60 | 2 years | |
| Irwin Scher | M | 84 | 3 years | |
| David S. McCullough | M | 59 | 5 years | |
| Lothar H. Finke | M | - | 9 years | |
| Hans-Joachim Lohrisch | M | 75 | 21 years | |
| Hans-Joachim Langmann | M | - | 39 years | |
| Dorothea Wenzel | M | 55 | 17 years | |
| Bernhard R. M. Ehmer | M | 69 | 8 years | |
| Nigel Williams | M | - | 11 years | |
| Crocifissa Attardo | F | 62 | 23 years | |
| Mechthild Auge | M | 66 | 18 years | |
| Thomas Lander | M | 71 | - | |
| Thomas Kuhn | M | 50 | - | |
| Daniel Cravo | M | - | - | |
| Uta Kemmerich-Keil | F | 58 | 19 years | |
| Kenneth B. Newman | M | 66 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 3 years |
| Peter F. Lang | M | 52 | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 59 | 59.60% |
| Germany | 25 | 25.25% |
| United Kingdom | 14 | 14.14% |
| China | 5 | 5.05% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Rajkumar Kannan
- Personal Network
